Virological Therapeutic Failure and Associated Factors in People Living with HIV Followed up at the Regional Hospital and University of Borgou (RHU-B) in 2019
Introduction: Antiretroviral treatment has made a considerable reduction in morbidity and mortality in HIV patients, but its effectiveness is compromised by the emergence of cardiovascular and metabolic diseases and also treatment failure. The goal is to study Virological therapeutic failure and the factors associated with HIV patients followed at RUH-B. Methods: This was a cross-sectional, descriptive and analytical study covering the period from 21st July to 21st September 2019. The study enrolled patients 18 years old and above, on antiretroviral treatment for at least 6 months. For the survey, a questionnaire and review of the medical records were used. The variable studied was virological treatment failure. Data analysis was performed using EPI-INFO version 7 and STATA 11 software. The significance level was 5%. Results: A total of 498 patients were included in the study. The mean age was 40 ± 9.90 years. The sex ratio was 0.3. The frequency of treatment failure was 15.3%. The factors associated with the occurrence of treatment failure were: phytotherapy, occurrence of opportunistic infections during follow-up, poor compliance with antiretrovirals, lack of weight gain and anemia during follow-up. Conclusion: This study had shown that treatment failure was frequent in patients. The systematic investigation for failure should be done in all people living with HIV patients on antiretrovirals.
References
[1]
Henerico, S., Mikasi, S.G., Kalluvya, S.E., Brauner, J.M., Abdul, S., Lyimo, E., et al. (2022) Prevalence and Patterns of HIV Drug Resistance in Patients with Suspected Virological Failure in North-Western Tanzania. Journal of Antimicrobial Chemothera-py, 77, 483-491. https://doi.org/10.1093/jac/dkab406
[2]
Mbange, A.E., Diouara, A., Diop-Ndiaye, H., Diouf, N., Ngom-Ngueye, N., Touré, K., et al. (2021) High HIV-1 Virological Failure and Drug Resistance among Adult Patients Receiving First-Line ART for At least 12 Months at a Decentralized Urban HIV Clinic Setting in Senegal before the Test-and-Treat. Infectious Diseases: Research and Treatment, 14, 1-16. https://doi.org/10.1177/11786337211014503
[3]
Lailulo, Y., Kitenge, M., Jaffer, S., Aluko, O. and Nyasulu, P. (2020) Factors Associated with Antiretroviral Treatment Failure among People Living with HIV on Antiretroviral Therapy in Resourcepoor Settings: A Systematic Review and Metaanalysis. Systematic Reviews, 9, Article No. 292. https://doi.org/10.1186/s13643-020-01524-1
[4]
Li, J., Xu, Y., Liu, J., Yang, B., Yang, C., Zhang, M., et al. (2019) Drug Resistance Evolution in Patients with Human Immunodeficiency Virus-1 under Long-Term Antiretroviral Treatment-Failure in Yunnan Province, China. Virology Journal, 16, Article No. 5. https://doi.org/10.1186/s12985-018-1112-6
[5]
Kearney, M.F., Spindler, J., Wiegand, A., Shao, W., Haubrich, R., Riddler, S., et al. (2018) Lower Pre-ART Intra-Participant HIV-1 pol Diversity May Not Be Associated with Virologic Failure in Adults. PLoS ONE, 13, e0190438. https://doi.org/10.1371/journal.pone.0190438
[6]
Azamar-Alonso, A., Mbuagbaw, L., Smail, F., Bautista-Arredondo, S., Costa, A. and Tarride, J. (2022) Virologic Failure in People Living with HIV in 1st Line ART: A 10-Year Mexican Population-Based Study. International Journal of STD & AIDS, 33, 363-372. https://doi.org/10.1177/09564624211067036
[7]
Buju, R.T., Akilimali, P.Z., Kamangu, E.N., Mesia, G.K., Kayembe, J.M.N. and Situakibanza, H.N. (2022) Predictors of Viral Non-Suppression among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study. International Journal of Environmental Research and Public Health, 19, Article No. 1085. https://doi.org/10.3390/ijerph19031085
[8]
Kebede, F., Kebede, B., Kebede, T. and Giza, M. (2021) Time to First-Line Antiretroviral Treatment Failure and Its Predictors for Seropositive Children Treated in Public Hospitals, North West Ethiopia 2021. Journal of Antivirals & Antiretrovirals, 21, 1-9.
[9]
Ba, S., Ba, N.D., Sembene, L., Dia, H., Coulibaly, M., Ndiaye, J.L., et al. (2019) Prevalence and Factors Associated withVirologic Failure among People Living with HIV (PLHIV) Monitored in a Decentralized Health Care Facility. Advances in Infectious Diseases, 9, 226-237. https://doi.org/10.4236/aid.2019.93016
[10]
Shah, G.H., Maluantesa, L., Etheredge, G.D., Waterfield, K.C., Ikhile, O. and Beni, R. (2022) HIV Viral Suppression among People Living with HIV on Antiretroviral Therapy in Haut-Katanga and Kinshasa Provinces of Democratic Republic of Congo. Healthcare, 10, Article No. 69. https://doi.org/10.3390/healthcare10010069
[11]
Ly, H., Kelly, M., Fall, M., Fall-Malic, F.Z., Kan, C.T. and Lo, B. (2021) Prevalence of Therapeutic Failure and Evolution of Biological Factors amongst People Living with HIV Enrolled in Antiretroviral Therapy at the Ambulatory Treatment Center in Nouakchott, Mauritania. Journal of Medical Virology, 93, 3621-3626. https://doi.org/10.1002/jmv.26562
[12]
Emagnu, A., Abay, Z., Bulti, A.B. and Animut, Y. (2020) Determinants of Virologic Failure among Adult HIV Patients on First-Line Antiretroviral Therapy at Waghimra Zone, Northern Ethiopia: A Case-Control Study. Advances in Public Health, 2020, Article ID: 1929436. https://doi.org/10.1155/2020/1929436
[13]
Jones, H.S., Floyd, S., Stangl, A., et al. (2020) Association between HIV Stigma and Antiretroviral Therapy Adherence among Adults Living with HIV: Baseline Findings from the HPTN 071 (PopART) Trial in Zambia and South Africa. Tropical Medicine & International Health, 25, 1246-1260. https://doi.org/10.1111/tmi.13473
[14]
Sithole, Z., Mbizvo, E., Chonzi, P., et al. (2018) Virological Failure among Adolescents on ART, Harare City, 2017—A Case-Control Study. BMC Infectious Diseases, 18, Article No. 469. https://doi.org/10.1186/s12879-018-3372-6
[15]
Ortiz, D.W., Roberts-Sano, O., Marroquin, H.E., Larson, L., Franco, K.B., Spec, A., et al. (2021) Factors Associated with Viremia in People Living with HIV on Antiretroviral Therapy in Guatemala. AIDS Research and Therapy, 18, Article No. 79. https://doi.org/10.1186/s12981-021-00400-9
[16]
Melsew, Y.A., Terefe, M.W., Tessema, G.A. and Ayele, T.A. (2013) Rate of Immunological Failure and Its Predictors among Patients on Highly Active Antiretroviral Therapy at Debremarkos Hospital, Northwest Ethiopia: A Retrospective Follow up Study. Journal of AIDS & Clinical Research, 4, Article ID: 1000211.
